In this article, Randall Stanicky, Chief Financial Officer of Click Therapeutics, talks about the transformative potential of “smart drugs” in healthcare and how these advanced therapeutics are poised to revolutionize treatment paradigms by offering personalized and adaptive interventions. This article explores the integration of technology in drug development and delivery, highlighting the promise of improved patient outcomes and more efficient healthcare solutions. Read the full article in Endeavor Venture Funds' Substack to gain a comprehensive understanding of how smart drugs are shaping the future of medicine.